Ultimate magazine theme for WordPress.

BioHarvest signs its first US supply agreement with Royal Emerald Pharmaceuticals- CEO discussion


CEO Ilan Sobel is joined by CEO Douglas Rosenberg of Royal Emerald Pharmaceuticals to discuss the new collaboration announced that same day, which will allow BioHarvest to supply cannabis products for research purposes to pharmaceutical companies, research institutions, and other DEA-registered entities in the United States federally, and opens the door to advance cannabis research initiatives towards drug development through cannabinoid combinations not found in nature.


Leave A Reply

Your email address will not be published.